Search Results - "Pasinetti, G"
-
1
Identification of potential CSF biomarkers in ALS
Published in Neurology (25-04-2006)“…The clinical diagnosis of ALS is based entirely on clinical features. Identification of biomarkers for ALS would be important for diagnosis and might also…”
Get full text
Journal Article -
2
Randomized pilot study of nimesulide treatment in Alzheimer's disease
Published in Neurology (09-04-2002)“…Nonsteroidal anti-inflammatory drugs (NSAID) may be useful in the treatment of AD. Clinical and laboratory experience with nimesulide, an NSAID with…”
Get full text
Journal Article -
3
The Palaeobiology of Two Crown Group Cnidarians: Haootia quadriformis and Mamsetia manunis gen. et sp. nov. from the Ediacaran of Newfoundland, Canada
Published in Life (Basel, Switzerland) (30-08-2024)“…The Ediacaran of eastern Newfoundland preserves the world's oldest known eumetazoan body fossils, as well as the earliest known record of fossilized muscular…”
Get full text
Journal Article -
4
Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
Published in Neuroscience (01-11-1998)“…Many epidemiological studies suggest that use of non-steroidal anti-inflammatory drugs delays or slows the clinical expression of Alzheimer's disease, [13]but…”
Get full text
Journal Article -
5
Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders
Published in Neuroscience (29-09-2010)“…Abstract The identification of biomarkers represents a fundamental medical advance that can lead to an improved understanding of disease pathogenesis, and…”
Get full text
Journal Article -
6
-
7
-
8
A therapeutic role for cyclooxygenase‐2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis
Published in The FASEB journal (01-04-2003)“…ABSTRACT Recent studies indicate that the proinflammatory enzyme cyclooxygenase (COX)‐2, an enzyme involved in inflammatory cascades but also normal neuronal…”
Get full text
Journal Article -
9
Potentiation of Excitotoxicity in Transgenic Mice Overexpressing Neuronal Cyclooxygenase-2
Published in The American journal of pathology (01-09-1999)“…In this study we describe the generation of a transgenic mouse model with neuronal overexpression of the human cyclooxygenase-2, h(COX)-2, to explore its role…”
Get full text
Journal Article -
10
Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia
Published in Archives of gerontology and geriatrics (01-08-2001)“…Industry and academia are devoting a tremendous amount of resources to the testing of anti-inflammatory drugs for the treatment of Alzheimer's disease (AD)…”
Get full text
Journal Article -
11
Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia
Published in Journal of neuroscience research (15-09-2001)“…Alzheimer's disease (AD) is the most common form of dementia, affecting as many as 4 million older persons and results from abnormal changes in the brain that…”
Get full text
Journal Article -
12
Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease
Published in Molecular psychiatry (01-02-2006)“…The present study was designed to further explore the potential cause/effect relationship between the expression of both the N141I presenilin (PS)2 mutant…”
Get full text
Journal Article -
13
Maturational Regulation and Regional Induction of Cyclooxygenase-2 in Rat Brain: Implications for Alzheimer's Disease
Published in Experimental neurology (01-04-1997)“…We explored the constitutive expression, maturational regulation, and relation to kainic-acid-induced apoptosis of cyclooxygenase (COX)-2 mRNA in rat brain. In…”
Get full text
Journal Article -
14
Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: The role of AKT
Published in Neuroscience (2004)“…We have reported recently that the microtubule-associated protein tau is phosphorylated in vitro by Akt, an important kinase in anti-apoptotic signaling…”
Get full text
Journal Article -
15
Protein Kinase C Anchoring Deficit in Postmortem Brains of Alzheimer's Disease Patients
Published in Experimental neurology (01-10-1999)“…Protein kinase C (PKC) has been implicated in the pathophysiology of Alzheimer's disease (AD). The levels of particular isoforms and the activation of PKC are…”
Get full text
Journal Article Conference Proceeding -
16
Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ 1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress
Published in Experimental neurology (01-11-1995)“…Clusterin (apoJ), a multifunctional apolipoprotein made by cells in the brain and many other locations, is associated with aggregated amyloid β-peptide (Aβ) in…”
Get full text
Journal Article -
17
Complement anaphylatoxin C5a neuroprotects through mitogen‐activated protein kinase‐dependent inhibition of caspase 3
Published in Journal of neurochemistry (01-04-2001)“…We previously reported that pretreatment of murine cortico‐hippocampal neuronal cultures with the complement‐derived anaphylatoxin C5a, protects against…”
Get full text
Journal Article -
18
Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration
Published in Neuroscience (01-02-1999)“…In this study we explored the potential role of the complement derived anaphylatoxin C5a and the expression of its receptor in mouse brain. Using in situ…”
Get full text
Journal Article -
19
Cyclooxygenase-2 Promotes Amyloid Plaque Deposition in a Mouse Model of Alzheimer's Disease Neuropathology
Published in Gene expression (01-01-2002)“…Several epidemiologic studies have reported that cyclooxygenase (COX) inhibitors prevent/delay the onset of Alzheimer's disease (AD). Recent experimental…”
Get full text
Journal Article -
20
Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions
Published in Journal of neuroscience research (01-10-1998)“…Many epidemiological studies suggest that use of non‐steroidal anti‐inflammatory drugs (NSAIDs) delay or slow the clinical expression of Alzheimer's disease…”
Get full text
Journal Article